Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Elderly, Surgery, Analgesia, Dexmedetomidine or Long-term Outcome
and you are
between 65 and 90
years old
The phase for this study is not defined.
Show me locations

The purpose

A majority of the elderly patients undergo surgery for malignant tumors. For these patients, postoperative tumor recurrence and metastasis are main factors that worsen long-term outcomes. The investigators hypothesize that dexmedetomidine supplemented analgesia in elderly patients after cancer surgery may help to maintain immune function and improve long-term outcomes, possibly by relieving stress and inflammatory response, improving analgesic efficacy and sleep quality, and reducing delirium incidence.

Provided treatments

  • Drug: Dexmedetomidine supplemented morphine analgesia
  • Drug: Morphine analgesia
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03012971. The sponsor of the trial is Peking University First Hospital and it is looking for 1500 volunteers for the current phase.
Official trial title:
Impact of Dexmedetomidine Supplemented Analgesia on Long-term Survival in Elderly Patients After Cancer Surgery: a Multicenter Randomized Controlled Trial